Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Spinomix Announces a Milestone Payment from Debiopharm

Published: Thursday, January 09, 2014
Last Updated: Wednesday, January 08, 2014
Bookmark and Share
Appointment of Nasri Nahas as Company’s new CEO.

Spinomix SA and Debiopharm Group™ have announced the successful achievement of a second development milestone on Spinomix’ two proprietary technologies, namely MagPhase™ and FibroTrap™.

In conjunction with the terms of the investment agreement, Spinomix is to receive an undisclosed second tranche payment from Debiopharm.

In January 2013, Spinomix closed its series A $ 3 million equity investment in a round led by Debiopharm. Since then, Spinomix has built a series of MagPhase™ pilot instruments for field-testing for purification of nucleic acids.

Four instruments were installed with academic and industry partners to initiate the field testing program. MagPhase™ is an automated sample preparation platform based on magnetic nanoparticles and microfluidic disposable cartridges offering cost-efficient and high quality DNA extraction.

Spinomix also successfully demonstrated the FibroTrap™ tube prototype assay in key applications laid out in the development plan. FibroTrap™ is a fibrinogen-based technology, enabling highly specific and sensitive isolation of targeted cells and molecules in clinical samples directly in routine collection tubes, thus simplifying enormously the workflow.

“This second milestone is an important achievement and marks the successful completion of a key step towards the establishment of new standards of improved workflow for diagnostic testing” said Heiner Dreisman, Chairman of the board of directors of Spinomix. “We are also very happy on the same occasion to announce that we have secured Nasri Nahas as our new CEO. Nasri’s broad experience of biotech startups management and business development makes him an ideal candidate to lead the next stage of Spinomix’ development.”

Nasri Nahas brings 20 years of experience in the biotech start-ups industry, from both the research and business perspectives. Over the course of his 12 years tenure as the CEO of Geneva Bioinformatics (GeneBio) SA, he lead GeneBio’s operations and successfully built an exceptional and highly motivated team of industry experts who grew the company from a start-up-like setting to an experienced, well-established and renowned organization. As CEO he personally oversaw the business development activities and expanded the company’s strategic network to encompass a wide palette of major industry players.

“Spinomix enjoys two amazing technologies in the growing diagnostics market and benefits from a unique team of industry experts backed by the instrumental support of our partnership with Debiopharm” said Nasri Nahas. “This makes Spinomix rightly suited to face the challenges that are ahead of us. I am very proud and thrilled to lead our next stages”.

“Our partnership with Spinomix has been very productive and the advancement of their diagnostic tools is a witness to their determination and professionalism. We are confident that the company will rapidly further develop these diagnostic sample treatment products for the delivery of faster, lower cost and more accurate results” added Thierry Mauvernay, Delegate of the Board of Debiopharm Group. “I am very pleased about Nasri Nahas joining the Spinomix’ team. He has significant experience in strategic management and we feel he is highly qualified to lead the company through the next stages of its development strategy”.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More than 5,000+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Point of Care Diagnostics - A Cautious Revolution
Advances in molecular biology, coupled with the miniaturization and improved sensitivity of assays and devices in general, have enabled a new wave of point-of-care (POC) or “bedside” diagnostics.
ReadCoor Launched to Commercialize 3D Sequencing Tech
ReadCoor will leverage the Wyss Institute’s method for simultaneously sequencing and mapping RNAs within cells and tissues to advance development of diagnostics.
Crispr Toolbox Expanded By Protein
Researchers have shown a newly discovered CRISPR protein has two distinct RNA cutting activities.
Heart Arrhythmia Caused by Mosaic of Mutant Cells
Researchers have solved the genetic mystery of an infant suffering from heart arrhythmia.
Over Two-Thirds of Cervical Cancer Deaths Prevented
Cervical screening prevents 70% of cervical cancer deaths and if all eligible women regularly attended screening this would rise to 83%.
Detecting Bacterial Infections in Newborns
Researchers tested an alternative way to diagnose bacterial infections in infants—by analyzing RNA biosignatures from a small blood sample.
Case for Liquid Biopsies Builds in Advanced Lung Cancer
Study addresses unmet need for better, non-invasive tests called out in recent "Moonshot" blue ribbon panel report
Mechanisms of Parkinson’s Pathology
Defects that lead to cells’ failure to decommission faulty mitochondria cause nerve cells to die, triggering the symptoms of Parkinson’s disease.
Genetic Misdiagnoses of Heart Condition
Analysis found several genetic variations previously linked with a heart condition were harmless, leading to condition misdiagnosis.
Opening Door to Oesophageal Cancer Targeted Treatments
Scientists have discovered that oesophageal cancer can be classified into three different subtypes.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!